erratum · Pharmaceuticals

Correction: Taha et al. Activation of SIRT-1 Pathway by Nanoceria Sheds Light on Its Ameliorative Effect on Doxorubicin-Induced Cognitive Impairment (Chemobrain): Restraining Its Neuroinflammation, Synaptic Dysplasticity and Apoptosis. Pharmaceuticals 2022, 15, 918

Medhat Taha
Abdullah G. Al-Kushi
Sara T. Elazab
Anas Sarhan
Naeem F. Qusty
Amira Osman
Alaa M. Badawy
Abdullah A. Saati
Amira E. Farage

2024Open accessMansoura University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

In the original publication [...]

Research topics

Advanced Nanomaterials in Catalysis
Cancer-related cognitive impairment studies
Nanoplatforms for cancer theranostics

Sustainable Development Goals

3Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.3390/ph17111533

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.